L. Reebel

Primary Results of the Multicenter ARISE II Study (Analysis of Revascularization in Ischemic Stroke With EmboTrap)

J. Mocco, B. Molyneaux, W. Hacke, 2018, Stroke.

A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors.

L. Coussens, H. Rugo, N. Sharma, 2014 .

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors

L. Coussens, H. Rugo, N. Sharma, 2019, Therapeutic advances in medical oncology.